These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 29459584)
41. Serum iron status among visceral leishmaniasis patients. Paul UK; Chakraborty PK; Hoque MR; Jafrin W; Sarkar S; Akhter S; Roy AS Mymensingh Med J; 2014 Oct; 23(4):654-7. PubMed ID: 25481581 [TBL] [Abstract][Full Text] [Related]
42. Altered Metabolism of Blood Manganese Is Associated with Low Levels of Hemoglobin in Patients with Chronic Kidney Disease. Kim M; Koh ES; Chung S; Chang YS; Shin SJ Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077007 [TBL] [Abstract][Full Text] [Related]
43. Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study. Yamamoto T; Miyazaki M; Nakayama M; Yamada G; Matsushima M; Sato M; Sato T; Taguma Y; Sato H; Ito S Clin Exp Nephrol; 2016 Aug; 20(4):595-602. PubMed ID: 26519375 [TBL] [Abstract][Full Text] [Related]
44. Effect of Obesity on Fasting Blood Sugar. Akter R; Nessa A; Husain MF; Wahed F; Khatun N; Yesmin M; Nasreen S; Tajkia T Mymensingh Med J; 2017 Jan; 26(1):7-11. PubMed ID: 28260748 [TBL] [Abstract][Full Text] [Related]
45. Serum Calcium Status among Pregnancies Complicated By Pre-Eclampsia in Bangladesh. Akhter S; Hoque MR; Paul UK; Hossain MM Mymensingh Med J; 2015 Oct; 24(4):657-60. PubMed ID: 26619999 [TBL] [Abstract][Full Text] [Related]
46. Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease. Cikrikcioglu MA; Karatoprak C; Cakirca M; Kiskac M; Zorlu M; Cetin G; Yildiz K; Erkoc R; Alay M; Erkal S; Erkal SN; Dogan S; Kazancioglu R Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2530-7. PubMed ID: 24089235 [TBL] [Abstract][Full Text] [Related]
47. Effects of stresses on serum cortisol level in Bangladeshi people. Hossain MZ; Latif SA; Khalil M Mymensingh Med J; 2006 Jan; 15(1):45-8. PubMed ID: 16467762 [TBL] [Abstract][Full Text] [Related]
48. A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial. Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Am J Kidney Dis; 2015 Jan; 65(1):49-57. PubMed ID: 25115616 [TBL] [Abstract][Full Text] [Related]
49. Association between Metabolic Syndrome and Acute Myocardial Infarction (AMI). Sarkar S; Paul BK; Chakraborty PK; Akhter S; Hossain MM; Hoque MR; Sarkar SR; Ferdousi S; Yesmin M Mymensingh Med J; 2016 Oct; 25(4):628-634. PubMed ID: 27941721 [TBL] [Abstract][Full Text] [Related]
50. Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Skali H; Lin J; Pfeffer MA; Chen CY; Cooper ME; McMurray JJ; Nissenson AR; Remuzzi G; Rossert J; Parfrey PS; Scott-Douglas NW; Singh AK; Toto R; Uno H; Ivanovich P Am J Kidney Dis; 2013 Feb; 61(2):238-46. PubMed ID: 23159232 [TBL] [Abstract][Full Text] [Related]
51. Relationship of BMI and Fasting Serum Glucose with Hypertension. Firoz S; Nessa A; Islam MF; Dipa MI; Yeasmin F; Sharmin A; Akter N; Israt S; Noor F; Rahman MH Mymensingh Med J; 2021 Jan; 30(1):56-61. PubMed ID: 33397851 [TBL] [Abstract][Full Text] [Related]
52. Blood pressure in different levels of BMI. Das RK; Nessa A Mymensingh Med J; 2013 Oct; 22(4):699-705. PubMed ID: 24292299 [TBL] [Abstract][Full Text] [Related]
53. Impact of hemoglobin concentration on plasma B-type natriuretic peptide level and left ventricle echocardiographics characteristics in chronic kidney disease patients. Rasić S; Hadzović-Dzuvo A; Tomić M; Uncanin S; Corić S Coll Antropol; 2009 Dec; 33 Suppl 2():141-4. PubMed ID: 20120531 [TBL] [Abstract][Full Text] [Related]
54. High Fibroblast Growth Factor 23 Levels Associated With Low Hemoglobin Levels in Patients With Chronic Kidney Disease Stages 3 and 4. Tsai MH; Leu JG; Fang YW; Liou HH Medicine (Baltimore); 2016 Mar; 95(11):e3049. PubMed ID: 26986127 [TBL] [Abstract][Full Text] [Related]
55. High serum adiponectin is associated with anemia development in chronic kidney disease: The results from the KNOW-CKD study. Kim H; Yun HR; Park S; Jhee JH; Park JT; Yoo TH; Lee KB; Kim YH; Sung SA; Lee J; Kang SW; Choi KH; Ahn C; Han SH Cytokine; 2018 Mar; 103():1-9. PubMed ID: 29287218 [TBL] [Abstract][Full Text] [Related]
56. Study of Serum Calcium and Magnesium Levels in Type 2 Diabetes Mellitus Patients. Faysal MR; Akter T; Hossain MS; Begum S; Banu M; Tasnim J; Sultana I; Krishna SP; Alam S; Akter T; Jenea AT Mymensingh Med J; 2023 Jan; 32(1):54-60. PubMed ID: 36594301 [TBL] [Abstract][Full Text] [Related]
57. Study of Serum Zinc Level in Patients with Type 2 Diabetes Mellitus. Faysal MR; Akter T; Hossain MS; Begum S; Banu M; Sarkar S; Krishna SP; Sultana I; Hoque MR Mymensingh Med J; 2023 Oct; 32(4):992-997. PubMed ID: 37777891 [TBL] [Abstract][Full Text] [Related]
58. Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial). Imai E; Maruyama S; Nangaku M; Hirakata H; Hayashi T; Narita I; Kono H; Nakatani E; Morita S; Tsubakihara Y; Akizawa T Clin Exp Nephrol; 2016 Feb; 20(1):71-6. PubMed ID: 26081567 [TBL] [Abstract][Full Text] [Related]